Forced licensing
Over the past few years, in the pharmaceutical sector there have been live discussions taking place on the possibility of introducing compulsory licensing for the purposes of regulatory practice, with the goal of reducing drug prices and increased access to treatment by the population. Some experts referred to the positive examples of international experience in the application of compulsory licenses (India, Thailand, Brazil, etc.), drawing analogies between the markets of developing countries and the market of the Russian Federation. At the same time, extreme caution needs to be used when borrowing solutions from international experience, regarding the use of compulsory licenses.